Learn more about whether Moderna, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

An institutional investor recently bought a new position in Silexion Therapeutics stock. Wildcat Capital Management LLC bought a new position in shares of Silexion Therapeutics Corp (NASDAQ ...

Every month, movies come and go on Amazon Prime Video. You might find something you want to watch one month only to realize that it’s already gone the next. This isn’t to say that every movie ...

During the last three months, 5 analysts shared their evaluations of Y-mAbs Therapeutics (NASDAQ:YMAB), revealing diverse outlooks from bullish to bearish. In the table below, you'll find a ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

Akebia Therapeutics shares were down 20% to $2.27 after the company priced its underwritten public offering of 25 million shares at $2 a share. All shares are being offered by Akebia. The proceeds ...

Shares of Five Below, Inc. FIVE rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.

To come up with the list, we considered only the companies with a $2-billion market capitalization and $5 million in trading volume. Sarepta Therapeutics bounced back by 8.74 percent on Wednesday ...

Although the youth-focused brand is growing its footprint, it’s aiming for the lower end of earlier new store projections. It could also face fresh tariff pain. Discount retailers have been hit ...

Making medicines cheaper is a tangible way we’re helping with the cost of living. Four out of five PBS medicines will become cheaper because of this $689 million investment in next week’s Budget. The ...

Five Below issued an upbeat outlook for its ... Shares surge 51%, to $23.40, in post-market trading. Akebia Therapeutics commenced an underwritten public offering. The biopharmaceutical company ...